VERONA PHARMA PLC's ticker is VRNA and the CUSIP is 925050106. A total of 9 filers reported holding VERONA PHARMA PLC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $11,356,000 | +143.9% | 1,111,112 | 0.0% | 29.98% | +77.5% |
| Q2 2022 | $4,656,000 | -16.0% | 1,111,112 | 0.0% | 16.89% | -0.0% |
| Q1 2022 | $5,544,000 | -25.8% | 1,111,112 | 0.0% | 16.90% | -10.6% |
| Q4 2021 | $7,467,000 | +22.6% | 1,111,112 | 0.0% | 18.90% | +123.9% |
| Q3 2021 | $6,089,000 | -16.2% | 1,111,112 | 0.0% | 8.44% | +9.6% |
| Q2 2021 | $7,267,000 | -21.8% | 1,111,112 | 0.0% | 7.70% | -5.6% |
| Q1 2021 | $9,289,000 | +34.0% | 1,111,112 | 0.0% | 8.16% | +58.0% |
| Q3 2020 | $6,933,000 | +247.7% | 1,111,112 | +437.6% | 5.16% | +688.1% |
| Q4 2018 | $1,994,000 | -68.2% | 206,663 | -58.7% | 0.66% | -52.6% |
| Q3 2018 | $6,266,000 | -8.8% | 500,883 | -0.4% | 1.38% | -6.5% |
| Q2 2018 | $6,869,000 | -39.2% | 502,825 | -11.1% | 1.48% | -40.0% |
| Q1 2018 | $11,306,000 | +80.2% | 565,292 | +7.0% | 2.46% | +40.0% |
| Q4 2017 | $6,273,000 | -32.9% | 528,422 | -13.2% | 1.76% | -31.6% |
| Q3 2017 | $9,346,000 | +30.7% | 608,851 | -0.8% | 2.57% | +10.2% |
| Q2 2017 | $7,152,000 | – | 613,601 | – | 2.34% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 2,369,000 | $47,095,720 | 7.54% |
| NEA Management Company, LLC | 5,108,563 | $111,024,890 | 7.40% |
| Vivo Capital, LLC | 4,249,918 | $84,488,370 | 6.92% |
| Aisling Capital Management LP | 1,115,352 | $22,173,198 | 6.61% |
| Rosalind Advisors, Inc. | 250,000 | $4,970,000 | 4.09% |
| First Turn Management, LLC | 1,206,291 | $23,981,065 | 3.44% |
| Knoll Capital Management, LLC | 200,000 | $3,976,000 | 3.29% |
| Frazier Life Sciences Management, L.P. | 3,014,349 | $59,925,258 | 3.20% |
| Tri Locum Partners LP | 293,112 | $5,827,067 | 2.66% |
| Carlyle Group Inc. | 2,457,500 | $48,805,950 | 2.35% |